Skip to main content
See the whole filing, with its images and exhibits
Contents

Appendix IIOperating Segments

APPENDIX II

Operating Segments for the years ended 31 December 2023, 2022 and 2021

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​ · ​ · Biopharma · ​ · Diagnostic · ​ · Bio Supplies · ​ · Others · ​ · Intersegments · ​ · Consolidated
​ · 2023 · 2022 · 2021 () · ​ · 2023 · 2022 · 2021 () · 2023 · 2022 · 2021 () · 2023 · 2022 · 2021 () · 2023 · 2022 · 2021 () · ​ · 2023 · 2022 · 2021 ()
Revenues from external customers5,558,3015,005,3823,814,983​670,269671,292779,108159,957146,076115,811203,450250,165266,461—(8,948)(43,245)​6,591,9776,063,9674,933,118
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Total operating income5,558,3015,005,3823,814,983​670,269671,292779,108159,957​146,076​115,811​203,450​250,165​266,461​—​(8,948)​(43,245)​6,591,9776,063,9674,933,118
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Profit/(Loss) for the segment904,059791,339681,925​111,694129,968152,94843,563​114,397​39,901​6,632​(46,809)​(83,482)​6,979​35,419​(10,896)​1,072,9271,024,314780,396
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated expenses​​​​​​​​​​​​​​​​​​​(273,529)(218,634)(185,332)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Operating profit/(loss)​​​​​​​​​​​​​​​​​​​799,398805,680595,064
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Finance result​​​​​​​​​​​​​​​​​​​(574,458)(442,941)(277,799)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Share of profit/(loss) of equity- accounted investee​—​—​—​—​—​—​—​—​—​(922)​(1,482)​33,188​—​—​—​(922)​(1,482)​33,188
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Income tax expense​​​​​​​​​​​​​​​​​​​(43,349)(90,111)(85,126)
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Profit for the year after tax​​​​​​​​​​​​​​​​​​​180,669271,146265,327
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Segment assets13,411,36913,187,6519,467,378​3,528,8613,681,6323,513,991380,012​341,876​47,446​2,184,960​766,139​827,371​—​(6,997)​(39,963)​19,505,20217,970,30113,816,223
Equity-accounted investments57,52941,16231,847​————​—​53,264​477,441​1,914,015​1,914,665​—​—​—​534,9701,955,1771,999,776
Unallocated assets———​————​—​—​—​—​—​—​—​—​1,400,8821,608,4993,417,836
Total assets​​​​​​​​​​​​​​​​​​​21,441,05421,533,97719,233,835
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Segment liabilities2,449,947​2,317,191​1,521,634​466,953​425,693​397,86979,678​43,264​27,596​97,840​222,565​199,095​—​—​—​3,094,4183,008,7132,146,194
Unallocated liabilities—​—​—​—​—​——​—​—​—​—​—​—​—​—​10,374,15110,067,7209,770,543
Total liabilities​​​​​​​​​​​​​​​​​​​13,468,56913,076,43311,916,737
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Other information:​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Allocated amortisation and depreciation328,599294,156228,114​65,81764,68288,5579,280​5,759​2,948​16,162​20,367​19,043​—​—​—​419,858384,964338,662
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated amortisation and depreciation———​————​—​—​—​—​—​—​—​—​500,273482,852412,314
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Allocated expenses that do not require cash payments30,198(71,964)26,051​6,99513,6394,446136​120​73​(789)​(206)​3,349​—​—​—​36,540(58,411)33,919
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated expenses that do not require cash payments———​————​—​—​—​—​—​—​—​—​548(10,770)4,991
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Allocated additions for the year of property, plant & equipment, intangible assets and rights of use458,216402,672349,890​29,10749,89019,9919,066​98​13,836​3,884​30,192​28,597​—​—​—​500,273482,852412,314
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Unallocated additions for the year of property, plant & equipment, intangible assets and rights of use———​————​—​—​—​—​—​—​—​—​48,61859,86655,380
  • As a consequence of the review of transactions and balances allocations by segments done in 2022, the comparative figures for the fiscal year 2021 have been adjusted accordingly.

This appendix forms an integral part of note 5 to the consolidated financial statements.

APPENDIX II

Reporting by geographical area

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​ · ​ · Spain · ​ · Rest of European Union · ​ · USA + Canada · ​ · Rest of World · ​ · Consolidated
​202320222021202320222021202320222021202320222021202320222021
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Net Revenue362,877320,631362,407893,050711,579544,0423,898,9613,855,6073,154,5491,437,0891,176,150872,1206,591,9776,063,9674,933,118
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Assets by geographical area1,190,6061,156,0681,092,4357,055,1816,600,2645,393,40710,958,65711,561,06810,525,1402,236,6102,216,5772,222,85321,441,05421,533,97719,233,835
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
Other information:
Additions for the year of property, plant & equipment, intangible assets and rights of use53,21660,50371,022170,763​107,03091,388313,001363,034295,52611,91112,1519,758548,891542,718467,694

This appendix forms an integral part of note 5 to the consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.